Comments
Aurobindo Pharma will be issuing one bonus equity share for every one equity share held in the company as on the record date.
A proposal in this regard was approved by the shareholders of the Hyderabad-based company at an extraordinary general meeting held on Thursday, the BSE was informed. Earlier, in May, the board of directors of the company had approved the proposal to issue bonus shares.
The Aurobindo Pharma scrip gained 0.45 per cent on the BSE on Thursday to end at ₹1,451.15.
Its consolidated net profit declined 19 per cent to ₹404 crore in the fourth quarter ended March 31, 2015, against ₹502 crore in the corresponding quarter of the previous financial year. For the full-year ended March, Aurobindo posted 34.3 per cent increase in net profit at ₹1,576 crore (₹1,172 crore).
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.